Antigen tests have reduced sensitivity to omicron: FDA
The U.S. Food and Drug Administration revealed new data on the efficacy of antigen tests for detecting the omicron COVID-19 variant.
The data so far suggests the tests do detect the variant, but they may have reduced sensitivity, the agency said.
The FDA and National Institutes of Health will continue to review the antigen tests' performance on the variant.